+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Radiation Oncology Market Research Report by Type (Brachytherapy, External Beam Radiation Therapy, and Radioisotope Therapy), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4968884
  • Report
  • April 2022
  • Region: Global
  • 215 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Accuray Incorporated
  • C.R. BARD, INC. (BD)
  • Curium Pharma
  • Elekta AB
  • Hitachi, LTD.
  • Isoray Medical
The Global Radiation Oncology Market size was estimated at USD 11.43 billion in 2021, USD 12.14 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.41% to reach USD 16.60 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Radiation Oncology to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Brachytherapy, External Beam Radiation Therapy, and Radioisotope Therapy. The External Beam Radiation Therapy is further studied across 3D Conformal Radiation Therapy, Modulated Radiation Therapy, Photon Beam Radiation Therapy, and Stereotactic Radiation.
  • Based on Application, the market was studied across Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer, and Skin Cancer.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Radiation Oncology market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Radiation Oncology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Radiation Oncology Market, including Accuray Incorporated, C.R. BARD, INC. (BD), Curium Pharma, Elekta AB, Hitachi, LTD., Ion Beam Applications (IBA), Isoray Medical, Nordion Inc., NTP Radioisotopes SOC Ltd., Optivus Proton Therapy, Inc., P-Cure LTD., Panacea Medical Technologies Pvt. LTD., Provision Healthcare, LLC., Sumitomo Heavy Industries, LTD, Theragenics Corporation, Varian Medical Systems, Inc., and Viewray Technologies, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Radiation Oncology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Radiation Oncology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Radiation Oncology Market?
4. What is the competitive strategic window for opportunities in the Global Radiation Oncology Market?
5. What are the technology trends and regulatory frameworks in the Global Radiation Oncology Market?
6. What is the market share of the leading vendors in the Global Radiation Oncology Market?
7. What modes and strategic moves are considered suitable for entering the Global Radiation Oncology Market?
Frequently Asked Questions about the Global Radiation Oncology Market

What is the estimated value of the Global Radiation Oncology Market?

The Global Radiation Oncology Market was estimated to be valued at $11.4 Billion in 2021.

What is the growth rate of the Global Radiation Oncology Market?

The growth rate of the Global Radiation Oncology Market is 6.4%, with an estimated value of $16.6 Billion by 2027.

What is the forecasted size of the Global Radiation Oncology Market?

The Global Radiation Oncology Market is estimated to be worth $16.6 Billion by 2027.

Who are the key companies in the Global Radiation Oncology Market?

Key companies in the Global Radiation Oncology Market include Accuray Incorporated, C.R. BARD, INC. (BD), Curium Pharma, Elekta AB, Hitachi, LTD., Ion Beam Applications (IBA), Isoray Medical, Nordion Inc. and Optivus Proton Therapy, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accuray Incorporated
  • C.R. BARD, INC. (BD)
  • Curium Pharma
  • Elekta AB
  • Hitachi, LTD.
  • Isoray Medical

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cancer patients
5.1.1.2. Lucrative reimbursement plans
5.1.1.3. Increasing elderly population, and technological advancements
5.1.2. Restraints
5.1.2.1. Lack of skilled radiotherapy professionals
5.1.2.2. Lack of training and education in radiation oncology among physicians in developing countries
5.1.3. Opportunities
5.1.3.1. Huge government and non-government investments in R&D of cancer treatment
5.1.3.2. Increasing healthcare spending, growing patient pool, and increasing healthcare awareness globally
5.1.3.3. Technological advancements to improve treatment safety and efficacy for radiation oncology treatment
5.1.4. Challenges
5.1.4.1. High cost of instrument and therapy, side effects
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Radiation Oncology Market, by Type
6.1. Introduction
6.2. Brachytherapy
6.3. External Beam Radiation Therapy
6.3.1. 3D Conformal Radiation Therapy
6.3.2. Modulated Radiation Therapy
6.3.3. Photon Beam Radiation Therapy
6.3.4. Stereotactic Radiation
6.4. Radioisotope Therapy
7. Radiation Oncology Market, by Application
7.1. Introduction
7.2. Blood Cancer
7.3. Breast Cancer
7.4. Gastrointestinal Cancer
7.5. Prostate Cancer
7.6. Respiratory/Lung Cancer
7.7. Skin Cancer
8. Americas Radiation Oncology Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Radiation Oncology Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Radiation Oncology Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Accuray Incorporated
12.2. C.R. BARD, INC. (BD)
12.3. Curium Pharma
12.4. Elekta AB
12.5. Hitachi, LTD.
12.6. Ion Beam Applications (IBA)
12.7. Isoray Medical
12.8. Nordion Inc.
12.9. NTP Radioisotopes SOC Ltd.
12.10. Optivus Proton Therapy, Inc.
12.11. P-Cure LTD.
12.12. Panacea Medical Technologies Pvt. LTD.
12.13. Provision Healthcare, LLC.
12.14. Sumitomo Heavy Industries, LTD
12.15. Theragenics Corporation
12.16. Varian Medical Systems, Inc.
12.17. Viewray Technologies, Inc.
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL RADIATION ONCOLOGY MARKET: DYNAMICS
FIGURE 2. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TYPE, 2027
FIGURE 5. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY 3D CONFORMAL RADIATION THERAPY, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY 3D CONFORMAL RADIATION THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY MODULATED RADIATION THERAPY, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY MODULATED RADIATION THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PHOTON BEAM RADIATION THERAPY, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PHOTON BEAM RADIATION THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC RADIATION, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC RADIATION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY RADIOISOTOPE THERAPY, 2019-2027 (USD BILLION)
FIGURE 18. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY RADIOISOTOPE THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 20. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2027
FIGURE 22. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BLOOD CANCER, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BLOOD CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GASTROINTESTINAL CANCER, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY RESPIRATORY/LUNG CANCER, 2019-2027 (USD BILLION)
FIGURE 31. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY RESPIRATORY/LUNG CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SKIN CANCER, 2019-2027 (USD BILLION)
FIGURE 33. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SKIN CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 34. AMERICAS RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 35. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 36. BRAZIL RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 37. CANADA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 38. MEXICO RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 40. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. CHINA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. INDIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. INDONESIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. JAPAN RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. SINGAPORE RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. SOUTH KOREA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. TAIWAN RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. THAILAND RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. FRANCE RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. GERMANY RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. ITALY RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. NETHERLANDS RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. QATAR RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. RUSSIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. SAUDI ARABIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. SOUTH AFRICA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. SPAIN RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. UNITED ARAB EMIRATES RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. UNITED KINGDOM RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. GLOBAL RADIATION ONCOLOGY MARKET: FPNV POSITIONING MATRIX
FIGURE 65. GLOBAL RADIATION ONCOLOGY MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL RADIATION ONCOLOGY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY 3D CONFORMAL RADIATION THERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY 3D CONFORMAL RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY 3D CONFORMAL RADIATION THERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY 3D CONFORMAL RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY 3D CONFORMAL RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY MODULATED RADIATION THERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 20. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY MODULATED RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY MODULATED RADIATION THERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 22. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY MODULATED RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY MODULATED RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PHOTON BEAM RADIATION THERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 25. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY PHOTON BEAM RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY PHOTON BEAM RADIATION THERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 27. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY PHOTON BEAM RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY PHOTON BEAM RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC RADIATION, BY REGION, 2019-2027 (USD BILLION)
TABLE 30. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC RADIATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC RADIATION, BY STATE, 2019-2027 (USD BILLION)
TABLE 32. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC RADIATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC RADIATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY RADIOISOTOPE THERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 35. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY RADIOISOTOPE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY RADIOISOTOPE THERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 37. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY RADIOISOTOPE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY RADIOISOTOPE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 40. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BLOOD CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 41. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY BLOOD CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY BLOOD CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 43. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY BLOOD CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY BLOOD CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 46. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 48. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 51. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 53. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 56. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 58. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY RESPIRATORY/LUNG CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 61. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY RESPIRATORY/LUNG CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY RESPIRATORY/LUNG CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 63. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY RESPIRATORY/LUNG CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY RESPIRATORY/LUNG CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SKIN CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 66. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY SKIN CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY SKIN CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 68. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY SKIN CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY SKIN CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. AMERICAS RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 71. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 72. BRAZIL RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 73. CANADA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 74. MEXICO RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 75. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 76. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 77. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. CHINA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 79. INDIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 80. INDONESIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 81. JAPAN RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 83. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. SINGAPORE RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. SOUTH KOREA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 86. TAIWAN RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 87. THAILAND RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 89. FRANCE RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. GERMANY RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 91. ITALY RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. NETHERLANDS RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 93. QATAR RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. RUSSIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. SAUDI ARABIA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 96. SOUTH AFRICA RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 97. SPAIN RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 98. UNITED ARAB EMIRATES RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 99. UNITED KINGDOM RADIATION ONCOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. GLOBAL RADIATION ONCOLOGY MARKET: SCORES
TABLE 101. GLOBAL RADIATION ONCOLOGY MARKET: BUSINESS STRATEGY
TABLE 102. GLOBAL RADIATION ONCOLOGY MARKET: PRODUCT SATISFACTION
TABLE 103. GLOBAL RADIATION ONCOLOGY MARKET: RANKING
TABLE 104. GLOBAL RADIATION ONCOLOGY MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 105. GLOBAL RADIATION ONCOLOGY MARKET: MERGER & ACQUISITION
TABLE 106. GLOBAL RADIATION ONCOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 107. GLOBAL RADIATION ONCOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 108. GLOBAL RADIATION ONCOLOGY MARKET: INVESTMENT & FUNDING
TABLE 109. GLOBAL RADIATION ONCOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 110. GLOBAL RADIATION ONCOLOGY MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Accuray Incorporated
  • C.R. BARD, INC. (BD)
  • Curium Pharma
  • Elekta AB
  • Hitachi, LTD.
  • Ion Beam Applications (IBA)
  • Isoray Medical
  • Nordion Inc.
  • NTP Radioisotopes SOC Ltd.
  • Optivus Proton Therapy, Inc.
  • P-Cure LTD.
  • Panacea Medical Technologies Pvt. LTD.
  • Provision Healthcare, LLC.
  • Sumitomo Heavy Industries, LTD
  • Theragenics Corporation
  • Varian Medical Systems, Inc.
  • Viewray Technologies, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...